In order to provide evidence for the prevention of essential hypertension, many researchers have conducted a series of studies exploring the potential relationships between atrial natriuretic peptide (ANP) genetic polymorphism and essential hypertension [7,15,16]. The gene discussed is NPPA; the disease is hypertensive disorder.